Loading, please wait...
.webp&w=384&q=75){kind=logo}
Verifying...
Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
Hippocrates
The FSSAI recently issued a critical advisory regarding the inclusion of Withania somnifera in dietary products. This directive clarifies that manufacturers must prioritize Ashwagandha root extracts and roots in health supplements and nutraceuticals. Furthermore, the FSSAI emphasizes compliance with the 2016 regulations to ensure consumer safety across India.
Only certain plant parts are safe for human consumption according to Schedule IV of the 2016 regulations. Specifically, the advisory permits only the roots and Ashwagandha root extracts for use in nutraceuticals and functional foods. However, these ingredients must still adhere to prescribed limits and quality standards. Consequently, manufacturers must verify their raw materials to meet these strict legal requirements.
Recent reports indicated that some manufacturers were using Ashwagandha leaves or leaf extracts in their products. Consequently, the FSSAI explicitly stated that the use of leaves in any form is currently not permitted. This decision aligns with previous directives from the Ministry of Ayush, which also limited product formulations to roots. Therefore, any product containing leaf-based ingredients is now considered non-compliant under the Food Safety and Standards Act of 2006.
Food Business Operators (FBOs) must ensure their products align with these updated guidelines immediately. Furthermore, licensing authorities and food safety officers are now under instructions to maintain strict vigilance. Any observed deviation from these standards will lead to legal action. As a result, businesses should review their formulations to avoid penalties and ensure public health safety.
Q1: Which parts of Ashwagandha are allowed in food products?
Only the roots and Ashwagandha root extracts are permitted under current FSSAI regulations for health supplements and nutraceuticals.
Q2: Why are Ashwagandha leaves prohibited?
The FSSAI and Ministry of Ayush have not authorized the use of leaves in food products, focusing on the historical and safety data associated with the roots.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References
Link will be sent via SMS to your number.
FSSAI issues an advisory restricting Ashwagandha use in food products to roots and extracts only, prohibiting the use of leaves due to safety regulations....
2 months ago
Hantaviruses are evolving from localized rural diseases into a global public health threat driven by climate change. This article examines the importance of the One Health approach in Southeast Europe to manage rodent reservoirs and prevent zoonotic spillover as environmental conditions shift.
Today
A study on 294 women after the Kahramanmaras earthquake shows that death distress, especially death depression, significantly influences fertility intentions. Key factors include age, income, and trauma experience, highlighting the need for mental health support in post-disaster care.
Today
Recent research highlights mussel-inspired catechol-amine copolyether brushes as a breakthrough in antifouling. By achieving high grafting density and maintaining chemical integrity, these coatings effectively prevent biofilm formation on medical devices, offering a substrate-independent solution for clinicians.
Today
A randomized controlled trial compared static stretching and myofascial release for hamstring tightness in IT professionals. While both methods improved flexibility, myofascial release demonstrated superior results in range of motion and functional scores over a three-week treatment period.
Today
Recent research identifies miR-335-5p as a key regulator for redifferentiating BRAF-mutant thyroid cancers. Restoring this microRNA enhances iodine uptake and inhibits EMT pathways, potentially resensitizing tumors to radioiodine and improving kinase inhibitor outcomes for refractory patients.
Today